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Dia2 ethylhexyl Phthalate in Bovine
Heart Muscle Mitochondria:
Its Detection, Characterization, and
Specific Localization
by Darius Jal Nazir,* Morton Beroza,I and Padmanabhan P. Nairt
During our studies on the fatty acid com-
position of several lipid classes of subcellular
fractions of bovine heart muscle, a peak
which constituted 60% of the total fatty
acids of mitochondrial triglycerides was con-
sistently observed in GLC runs 1,2). The
earlier assumption that this compound was
either an artifact or a contaminant was in-
consistent with the manner in which this
compound consistently appeared in such
proportions only in this single subcellular
fraction. The experiments to isolate this
component of mitochondrial triglycerides
and identify it as di-2-ethylhexyl phthalate
(DEHP) are described in this presentation.
Subcellular Fractionation
Fresh beef heart muscle was trimmed of
all excess fat and homogenized in an
EDTA-sucrose solution. Figure 1 shows the
procedure used for isolating the nuclear,
heavy and light mitochondrial, microsomal,
and cytoplasmic fractions by differential
centrifugation (3-5). All the subcellular
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fractions (after purification) were essentially
homogenous by electron microscopy.
Extraction and Column Chromatography
The lipids of all the subcellular fractions
were extracted according to the procedure
described by Folch (5, 6) and chromato-
graphed on silicic acid (7-9) (Table 1). The
unknown compound was eluted in the 4%
ether in hexane fraction, together with the
triglycerides.
Transmethylation
The fatty acids in the lipid fractions were
transmethylated in the presence of metha-
nol, hydrochloric acid, and dimethoxypro-
pane (8), and the resulting methyl esters
were analyzed by gas-chromatographic tech-
niques.
Gas-Liquid Chromatography
The methylated samples were run on
three phases: a polar 16% diethyleneglycol
succinate (DEGS) column, a relatively non-
polar 8% Apiezon L column, and a two-
phase SE52-XE60 column. Only the
triglyceride fraction of the lipid extracted
from heavy mitochondria showed the pres-
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FIGURE 1. Separation of beef heart muscle homogenate into subcellular frac-
tions (the centrifugal forces are given as Rmax).
ence of this unknown peak in appreciable
amounts. It had a retention time 13.6, 4.4,
and 4.6 times that of methyl octadecanoate
on these three phases, respectively (Table 2).
Preparative-Scale Gas-liquid Chromatography
The unknown compound was isolated
from the mitochondrial triglyceride fraction
by using a 10 ft x 8 mm DEGS column
maintained at 2000 C and at an argon gas
pressure of 30 psi.
Elemental Analysis
A quantitative determination of the ele-
ments present in this compound showed
73.64% of carbon, 9.64% of hydrogen and
16.70% of oxygen, which agreed closely
with the calculated values for C24H3804
(Table 3).
Microhydrogenation
In order to get some idea of the number
of double bonds present in the unknown
compound about 2 ,ug was subjected to
microhydrogenation as described by Beroza
and Sarmiento (10) (Table 4). A tubular by-
pass splitter was used; the catalyst was
"neutral" 1% palladium on 99% Gas Chrom
P. Hydrogen was the obligatory carrier gas,
while nitrogen was introduced into the port
at the flame head where hydrogen usually
enters in ordinary gas chromatography. The
vapor emerging from the hydrogenator was
passed through a DEGS column. Since no
change was observed on passing the sample
through the hydrogenator at 2000C, it was
probable that no aliphatic double bonds
were present.
Microozonization
Another 5-,ig aliquot of the unknown
compound was subjected to micro-
ozonization as described by Beroza and Bierl
(11). The compound was held at -60°C in a
solvent like methylene chloride during ozoni-
zation. Excess ozone resulted in the appear-
ance of side products, and therefore the
reaction was stopped as soon as the gas
emerging from the reaction chamber con-
tained ozone. The ozonized sample was sub-
jected to gas chromatography on a DEGS
column. No fragments were observed during
the gas chromatographic run, and once again
only a single peak was obtained, correspond-
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142Table 1. Steps in isolation of unknown compound from
beef heart muscle mitochondria. Carbon Skeleton Chromatography
Step
1. Subcellular fractionation
2. Extraction of fractions with chloroform: met
3. Chromatography of silicic acid
Solvent system
Hexane
1% Ether in hexane
4% Ether in hexane
8% Ether in hexane
Lipid class
Free aldehydes
hydrocarbons
and degrada-
tion products
Cholesterol esters
Triglycerides +
unknown
compound
Free fatty acids
4. Methylation of lipid from 4% ether in hexane
5. Gas-liquid chromatography of methylated fa
6. Isolation by preparative gas-liquid chromatol
on a 16% diethylene glycol succinate c(
Table 2. Retention time data on the unidentified
from bovine heart muscle mitochondrial trigi
relative to methyl octadecanoate.a
Stationary phases Unknown compound DEHP
Diethyleneglycol 13.6 13.5
succinateb
Apiezon LC 4*4 4.4
SE52/XE60 (2:1)d 4.6 4.6
a Methyl octadecanoate = 1.00
b Column temperature: 180CC; outlet flow rate; 75
ml/min.
c Column temperature: 200°C; outlet flow rate; 300
ml/min.
d Column temperature: 2000C; outlet flow rate; 250
ml/min.
The unknown compound was subjected to
carbon skeleton chromatography (12, 13).
The tube containing the catalyst (1% palladi-
thanol(2:1) um on Gas Chrom P) was screwed onto the
injection port of a gas chromatograph. The
Volume of carrier gas hydrogen swept the sample over
eluent, ml the catalyst whose temperature was main-
200 tained at 3000C. This resulted in the satura-
tion of multiple double bonds, if present,
and the replacement of halogen, oxygen,
500 nitrogen, and sulfur atoms by hydrogen. The
600 unknown compound gave peaks with reten-
tion times corresponding to n-heptane (11.9
min), a branched-chain hydrocarbon having
250 eight carbon atoms (3-methylheptane, which
fraction is 2-ethylhexane) (20.0 min), and a weak
tty acids peak for benzene (9.5 min). The breakdown
graphy pattern and the relative proportions in which
olumn each of the hydrocarbons was obtained sug-
gested the presence of a disubstituted ben-
component zene ring with a 2-ethylhexyl side chain in
the original molecule [eq. (1)]. Authentic
CH3
I
o CH2 III I
I- II C-O'CH24CH-CH2-CH2-CH2-CH3
I-OCH2,CH-CH2-CH2-CH2-CH3
II O OH2
CH3 (1)
[H] I +,
Table 3. Elemental Analysis: C24H3804.
C,% H,% O,%
Calculated 73.85 9.74 16.41
Found 73.64 9.64 16.70
CH3
I
OH2
CH33-CH-CH2-CH2-CH2-CH3
+
CH3
I
OH2
CH2-CH2-CH2-CH2-CH3
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ing to the original sample in both retention
time and peak area. The result again indi-
cated the absence of aliphatic double bonds.
143Table 4. Analytical procedures for the identification of
di-2-ethylhexyl phthalate.
Procedure Result
1. Hydrogenation followed by GLC
2. Microozonization followed by
GLC
3. Carbon-skeleton chromatography
4. Saponification (strong alkali)
DEHP gave products with retention times
identical to those obtained with the un-
known compound. These results indicated
that the unknown compound was probably
di-2-ethylhexyl phthalate. To show that it
was, the isolated compound and standard
DEHP were subjected to gas chroma-
tography, separately and together. The reten-
tion times were identical. The identity of
this compound was further confirmed by
other experimental evidence.
Saponification
The nonsaponifiable portion obtained
after drastic alkaline hydrolysis with 30%
aqueous KOH for 2 hr contained a single
component, having a retention time identical
to 2-ethyl-1-hexanol on DEGS, Apiezon L,
and SE52-XE60 columns (Table 5).
No change in retention time
No fragments produced
Revealed heptane, 2-ethylhexane,
and benzene (weak)
A. Nonsaponificable fraction
yielded 2-ethyl-i-
hexanol, identified
by GLC
B. Saponifiable fraction, after
methylation, gave
dimethyl phthalate,
identified by GLC
(10)
(11)
(12, 13)
The acidic portion, when subjected to gas
chromatography after methylation, gave only
one peak with the same retention character-
istics as o-dimethyl phthalate on all three
phases (Table 6). These results again indi-
cated that the unknown compound was di-2-
ethylhexyl phthalate.
Infrared Spectrum
The infrared spectrum of the isolated
component showed a band at 13.5,, indi-
cating the presence of an ortho-disubstituted
benzene ring (Fig. 2). Absorption bands at
7.9, 8.9, and 9.4 , were attributed to
carbon-oxygen absorption and are one of
the characteristics of phthalates; the band at
5.8 , was attributed to the ester carbonyl;
at 6.9 , to the aliphatic C-H; and at 7.3 ,u
to the methyl groups. The ratios indicated
Table 5. Retention time data for several closely related alcohols on three different stationary phases.
Retention time, min
Stationary Isobutyl Isoamyl
phase 1-Butanol alcohol alcohol 4-Heptanol 2-Ethyl-1-hexanol 1-Octanol 2-Octanol Unknowna
Diethylene
glycol
succinate 3.1 2.2 4.3 6.8 20.5 30.7 14.7 20.5
Apiezon L 1.7 9.3 25.2 35.3 21.4 25.2
SE52-XE60 2.0 6.4 17.4 24.9 13.6 17.4
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aUnknown sample represents the alcohol moiety of the compound isolated from bovine heart muscle mitochondria.
144Table 6. Retention time data ofo-, m-, and p- dimethyl
esters ofbenzenedicarboxylic acids on three different
stationary phases.
Stationary Retention time, min
phase Ortho Meta Para Unknowna
Diethylene
glycol
succinate 14.2 12.9 11.7 14.2
Apiezon L 2.4 3.8 3.8 2.4
SE52-XE60 2.3 2.7 2.5 2.3
a Unknown sample represents the methylated acid
moiety of the compound isolated from bovine
heart muscle mitochondria.
that the alcohol moiety was longer than
propyl, and possibly branched. These data
were consistent with the pattern expected
from a compound with the structure of
DEHP.
Mass Spectrum
The mass spectrum of the isolated com-
pound was identical with that of standard
DEHP (Fig. 3). Some of the peaks in this
figure have been amplified off scale in order
to show the parent peaks better. The molec-
ular formula established by peak matching
the molecular ion C24H3804+ was found to
be 390.2765, compared to a theoretical value
of 390.2770. The m/e values of fragments
with the highest relative abundance corre-
sponded to rearrangement ions of phthalic
anhydride (149; M-241); the diacid fragment
(167; M-223); the one derived by the loss of
a 2-ethylhexyl group from the parent molec-
ular ion (279; M-111); and a 2-ethylhexane
hydrocarbon fragment (11.2; M-278).
Nuclear Magnetic Resonance Spectrum
The NMR spectrum showed a pair of
overlapping triplets centered about 9.1, over-
lapping multiplets with the strongest peak at
8.7, a doublet at 5.9, and another multiplet
centered at 2.5 (Fig. 4). The chemical shifts
have been expressed in parts per million rela-
tive to tetramethylsilane at 10 ppm (r scale).
These data were consistent with the struc-
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FIGURE 4. Nuclear magnetic resonance spectrum
of di-2-ethylhexyl phthalate.
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FIGURE 5. Gas-liquid chromatographic separation
of the diesters of phthalic acid.
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145tural features of DEHP and were identical to
that obtained with the standard compound. DEHP in Heart Muscle of Other Species
Gas-Liquid Chromatography of Diesters of Phthalic Acid
The separation of several diesters of
phthalic acid on a 5% SE30 column is
shown in Figure 5. Although Perkins (14)
was unable to distinguish between di-2-
ethylhexyl phthalate and di-n-octyl
phthalate, our results show that these com-
pounds could be easily separated on a non-
polar column.
Subcellular Distribution in Heart Muscle Homogenate
The triglyceride fraction of the total lipids
obtained from the nuclear, heavy and light
mitochondrial, microsomal and cytoplasmic
fractions of bovine heart muscle homogenate
was transmethylated and subjected to gas
chromatography on a mixed-phase SE52-
XE60 column to quantitate the DEHP
(Table 7). The quantitation of DEHP in the
nuclear fraction was rendered inaccurate due
to the extremely low levels of DEHP in
relation to the other lipids in this fraction.
The DEHP obtained from the heavy mito-
chondrial fraction accounted for more than
99.5% of the total DEHP present in the cell.
Table 7. Distribution of di-2-ethylhexyl phthalate (DEHP)
among subcellular fractions from bovine heart muscle.
DEHP, DEHP, DEHP,
Subcellular mg/100 g mg/100H mg/100 g
muscle total lipid a triglyceride b
Nuclear Trace c - -
Heavy mitochondrial 13.5 304.1 1752.6
Light mitochondrial 0.013 0.293 1.689
Microsomal 0.015 0.338 1.948
Cytoplasmic 0.033 0.743 4.283
a Represents the DEHP in 100 g of total lipid from whole heart
homogenate, distributed among subcellular fractions. Values
were computed from total lipid content of whole heart muscle
(4.44 g/100 g muscle).
b Represents the DEHP in 100 g of total triglyceride from
whole heart homogenate, distributed among subcellular frac-
tions. Values were computed from total triglyceride content
of whole heart muscle (0.77 g/100 g muscle).
c DEHP was found only in traces and could not be quantita-
tively determined.
Subcellular fractionation of the heart mus-
cle of the rat, rabbit, and dog was carried
out as described for bovine heart muscle.
Once again DEHP was present only in heavy
mitochondrial triglycerides, but in amounts
much smaller than that found in beef heart
mitochondria (Table 8). No DEHP was de-
tected in the triglycerides of the other sub-
cellular fractions of heart muscle of these
species.
Johnson and Roots (15) have suggested
that anhydrous methanolic HCl may be a
source of such artifacts as the esters of
carboxylic acids formed during methano-
lysis. These artifacts were assumed to have
been formed either by the oxidative break-
down of methanol coupled with condensa-
tion reactions, or simply to have been
present as contaminants in the methanol.
However, we were able to recover DEHP
quantitatively by direct gas-liquid chroma-
tography of mitochondrial triglycerides with-
out prior transmethylation, and conse-
quently any possibility of DEHP arising as an
artifact during methanolysis was eliminated.
Under our conditions of esterification, DEHP
was not attacked. Moreover, if DEHP was an
artifact formed during the experimental pro-
cedure, it should have appeared in all frac-
tions; the repeated observations that DEHP
was present in only one out of the fourteen
lipid fractions isolated by silicic acid chroma-
tography would rule out this possibility.
DEHP is a compound widely used as a
plasticizer in the production of tubing,
Table 8. Di-2-ethylhexyl phthalate in heart muscle
mitochondria from other species.
Species
Rat
Rabbit
Dog
DEHP, jga
129
118
36
a Expressed as jig of DEHP in mitochon-
dria derived from 100 g of original heart
muscle.
Environmental Health Perspectives 146synthetic resins, flexible films, and as an
additive in vacuum pump oils. Recent re-
ports have indicated that DEHP is present,
sometimes in relatively high concentrations,
in milk (16) and blood (17) stored in con-
tainers made of synthetic rubber and plastic,
presumably due to a leaching effect exerted
by the liquid. Yoshinori and Fumihide (18)
have reported the presence of DEHP in some
commercial solvents. However, our complete
control runs using the same redistilled solv-
ents and other reagents were essentially
negative, showing that DEHP did not orig-
inate as a contaminant from laboratory
reagents or equipment. All possible sources
of contamination were scrupulously avoided
during the processing of our samples. In
order to avoid any possible contamination
from polyethylene ultracentrifuge cups, sub-
cellular fractionation up to the stage of the
postmitochondrial supernatant was per-
formed in stainless steel containers in certain
experiments.
At this time there is no firm evidence to
show whether heart mitochondria could
possibly biosynthesize molecules like DEHP
from simpler compounds or whether they
arise from dietary sources and become
specifically localized in this subcellular
organelle. Esters of phthalic acid have been
reported to have been formed by thermal
oxidation, in vitro, of corn oil and triolein,
and Perkins (14) has speculated on the chem-
ical reactions leading to the aromatization of
linoleic and arachidonic acids.
Evidence from other laboratories shows
that compounds like terephthalic acid, if
present in the animal body, are rapidly elim-
inated (19, 20), but more recent reports
indicate that DEHP is not attacked by non-
specific esterases (21), and may thus con-
ceivably accumulate in animal tissues.
Our original observation of the presence
of DEHP in bovine heart muscle mito-
chondria has been extended more recently
to heart mitochondria of other species such
as the rat, rabbit, and dog. However, from
our preliminary work on other organs, we
have not been able to demonstrate the pres-
ence of DEHP in appreciable concentrations,
in tissues which are not related to the
cardiovascular system.
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